Ex­clu­sive: Strand lays off 18% of staff as its first mR­NA ther­a­pies head in­to the clin­ic

Less than a week af­ter an­nounc­ing that reg­u­la­tors have green­lit the first tests of its tu­mor-bust­ing mR­NA ther­a­py, Strand Ther­a­peu­tics has laid off rough­ly 18 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.